Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

albuferon

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
  • V. Rustgi
  • Current medical research and opinion
  • 2009
  • Corpus ID: 37168771
OBJECTIVE New treatment options for chronic hepatitis C (CHC) that offer improved efficacy, tolerability, and convenience… Expand
Is this relevant?
Review
2008
Review
2008
  • F. Kratz
  • Journal of controlled release : official journal…
  • 2008
  • Corpus ID: 2282830
Albumin is playing an increasing role as a drug carrier in the clinical setting. Principally, three drug delivery technologies… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Albuferon is a novel long-acting interferon resulted from the direct genetic fusion of human albumin and interferon-alpha2b (HSA… Expand
Is this relevant?
Review
2006
Review
2006
Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
The long half-life and stability of human serum albumin (HSA) make it an attractive candidate for fusion to short-lived… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Interferon-α (IFN-α) is indicated for the treatment of certain viral infections including hepatitis B and C, and cancers such as… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?